Raymond James Financial Inc Apellis Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 74,466 shares of APLS stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,466
Previous 51,978
43.26%
Holding current value
$1.47 Million
Previous $1.14 Million
13.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
306Shares Held
135MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$241 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$234 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$197 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$192 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$177 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.17B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...